miR-10a-5p inhibits cardiac fibrosis by targeting the MRTF-A/TGF-β2 feedback loop
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.111981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Chen Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology, Tianjin University of Science and Technology, 300457 Tianjin, PR China. Hauptthemen laut MEDLINE: MicroRNAs, Trans-Activators, Transforming Growth Factor beta2, Myocardium. Die Arbeit nennt 78 Literaturangaben. Gefördert von: Tianjin Municipal Education Commission.
Abstract (Originalsprache)
Cardiac fibrosis is a significant contributor to cardiac dysfunction and heart disease. The present study investigated the role of miR-10a-5p in mitigating cardiac fibrosis, potentially through its regulation of Myocardin-related transcription factor A (MRTF-A). RNA sequencing of heart samples obtained from patients with rheumatoid heart disease (RHD) revealed a marked reduction in miR-10a-5p expression in RHD patients exhibiting cardiac fibrosis, which was accompanied by an elevation in MRTF-A expression. In in vitro models of fibrosis, including primary myocardial fibroblasts and NIH3T3 cells treated with TGF-β, miR-10a-5p was shown to suppress cellular proliferation, migration, and the expression of fibrosis markers such as COL1A2, ACTA2, and SM-22α, through the targeted inhibition of MRTF-A. MRTF-A was identified as a pivotal regulator of fibrosis, and the use of siRNA targeting MRTF-A, as well as the ROCK inhibitor Y27632, both reduced MRTF-A expression and its nuclear localization. Furthermore, MRTF-A was found to positively regulate TGF-β2 expression. In vivo, administration of miR-10a-5p resulted in an improvement in cardiac function and a reduction in cardiac fibrosis in a mouse model. These findings suggest that miR-10a-5p may serve as a potential interventional target for cardiac fibrosis by inhibiting MRTF-A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology, Tianjin University of Science and Technology, 300457 Tianjin, PR China.
- Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, 430081 Wuhan, Hubei, PR China.
- College of Biotechnology, Tianjin University of Science and Technology, 300457 Tianjin, PR China; Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, 43008…
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, PR China. Electronic address: rxj@mail.tust.edu.cn.
- College of Biotechnology, Tianjin University of Science and Technology, 300457 Tianjin, PR China. Electronic address: nanwang@tust.edu.cn.
Förderung
- Tianjin Municipal Education Commission
Zitieren
APA
Liu, C., Ding, J., Chen, X., Zhang, F., Wang, Y., He, H., Liao, X., Zhang, T., Ren, X., & Wang, N. (2025). miR-10a-5p inhibits cardiac fibrosis by targeting the MRTF-A/TGF-β2 feedback loop. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.111981
Vancouver
Liu C, Ding J, Chen X, Zhang F, Wang Y, He H, et al. miR-10a-5p inhibits cardiac fibrosis by targeting the MRTF-A/TGF-β2 feedback loop. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.111981
BibTeX
@article{Liu2025,
author = {Liu, Chen and Ding, Jinhua and Chen, Xiaojie and Zhang, Fan and Wang, Ying and He, Hongpeng and Liao, Xinghua and Zhang, Tongcun and Ren, Xuejun and Wang, Nan},
title = {miR-10a-5p inhibits cardiac fibrosis by targeting the MRTF-A/TGF-β2 feedback loop},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.111981}
}
EUVIMED